BLACK DIAMOND THERAPEUTICS I's ticker is BDTX and the CUSIP is 09203E105.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $22,529 | +110.8% | 7,850 | +271.0% | 0.00% | – |
| Q2 2023 | $10,686 | +71140.0% | 2,116 | -72.3% | 0.00% | – |
| Q1 2023 | $15 | +150.0% | 7,627 | +120.1% | 0.00% | – |
| Q4 2022 | $6 | -99.9% | 3,465 | -18.9% | 0.00% | – |
| Q3 2022 | $7,000 | -36.4% | 4,275 | -4.0% | 0.00% | – |
| Q2 2022 | $11,000 | +10.0% | 4,455 | +25.2% | 0.00% | – |
| Q1 2022 | $10,000 | -83.3% | 3,558 | -68.4% | 0.00% | -100.0% |
| Q4 2021 | $60,000 | +200.0% | 11,249 | +367.9% | 0.00% | 0.0% |
| Q3 2021 | $20,000 | -16.7% | 2,404 | +23.5% | 0.00% | 0.0% |
| Q2 2021 | $24,000 | -33.3% | 1,947 | +31.2% | 0.00% | 0.0% |
| Q1 2021 | $36,000 | -53.8% | 1,484 | -39.2% | 0.00% | -50.0% |
| Q4 2020 | $78,000 | -81.7% | 2,439 | -82.8% | 0.00% | -60.0% |
| Q3 2020 | $427,000 | +306.7% | 14,140 | +466.5% | 0.01% | +25.0% |
| Q2 2020 | $105,000 | – | 2,496 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEA Management Company, LLC | 3,449,845 | $86,074,000 | 4.50% |
| Boxer Capital, LLC | 2,014,858 | $50,271,000 | 3.43% |
| RA Capital Management | 2,589,904 | $64,618,000 | 2.04% |
| Artal Group S.A. | 1,696,517 | $42,328,000 | 1.79% |
| Logos Global Management LP | 123,465 | $2,772,000 | 1.05% |
| BVF INC/IL | 378,788 | $9,451,000 | 0.88% |
| Casdin Capital, LLC | 289,395 | $7,220,000 | 0.77% |
| Perceptive Advisors | 1,104,656 | $27,561,000 | 0.72% |
| Bellevue Group AG | 1,330,000 | $33,184,000 | 0.64% |
| Vivo Capital, LLC | 252,119 | $6,290,000 | 0.57% |